DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Berger T, Rubner P, Schautzer F. , et al.
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event.
N. Engl. J. Med. 2003;
349: 139-145 .
We do not assume any responsibility for the contents of the web pages of other providers.